{"id":"W3024907887","doi":"10.1016/j.clml.2020.05.006","title":"A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Janssen Biotech; Roche Italia; Celgene; Bristol-Myers Squibb; Takeda Pharmaceutical Company; Takeda Canada; Novartis; Amgen","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Authorization; Observational study; Internal medicine; Multiple myeloma; Oncology; Expanded access","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001729861,0.0005950374,0.0009932261,0.000426098,0.000793433,0.001507041,0.0005914402,0.0008717726,0.002567542],"category_scores_gemma":[0.003867774,0.0004164095,0.001079816,0.0008961376,0.0007491483,0.00115081,0.000707841,0.001466761,0.0004586409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009871173,"about_ca_system_score_gemma":0.001370393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002273627,"about_ca_topic_score_gemma":0.00314006,"domain_scores_codex":[0.998181,0.0008926328,0.0001672257,0.0003531647,0.0001863363,0.000219664],"domain_scores_gemma":[0.9962299,0.000885112,0.001552006,0.0003620081,0.0003228942,0.0006480838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2006779,0.01104336,0.7655094,0.0003472271,0.004330718,0.0004171521,0.000595397,0.0002556623,0.002365798,0.0004000638,0.001788336,0.01226905],"study_design_scores_gemma":[0.04079475,0.0268876,0.9236255,0.00008510304,0.002008704,0.0006967533,0.000737545,0.0008298486,0.0005414661,0.0003960285,0.00331577,0.00008087757],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981545,0.0002759779,0.0001115153,0.00008265698,0.00001716588,0.0001302984,0.0005882358,0.000005481702,0.0006342444],"genre_scores_gemma":[0.9973387,0.0001527542,0.0001988833,0.0003547992,0.00007305994,0.0001733545,0.001306314,0.000005035086,0.0003971518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002567542,"threshold_uncertainty_score":0.009148479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06524772035819815,"score_gpt":0.3229437420080261,"score_spread":0.257696021649828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}